Underwriting the Buyer: Labs as Infrastructure Demand
The demand under this whole edifice comes from one place: AI labs buying compute at industrial scale. Every financing structure in this course ultimately rests on the labs' willingness and ability to keep paying for capacity. So the last discipline is to underwrite the buyer — to treat the AI lab not as a software customer but as the load-bearing counterparty of the entire infrastructure bet. If the buyer's demand is durable, the structures above it are financeable. If it is not, no amount of clever capital engineering saves them.
See the labs as infrastructure buyers first. A frontier lab's largest and most fateful commitment is compute. Training frontier models consumes vast, sustained capacity, and serving them to users consumes more. That makes the lab the anchor tenant behind the neoclouds, the ultimate source of the chip orders behind the chipmakers, and the counterparty whose contracts are pledged as security in the financing stack. When a neocloud borrows against a take-or-pay contract, that contract is a lab's promise to pay. When a chipmaker books soaring demand, much of it traces to labs building or renting clusters. The labs are the demand. Everything else is intermediation.
So underwrite the promise. An anchor contract is only as good as the counterparty behind it, and labs are unusual counterparties. Their revenue is young and growing fast but not always self-funding — many labs spend far more than they earn, bridging the gap with large equity raises. Their compute commitments can exceed their current revenue by a wide margin, which means the contract securing a neocloud's debt is backed less by today's cash flow than by the lab's continued ability to raise capital. That reframes the risk. When you lend against a lab's capacity commitment, you are partly underwriting the lab's access to funding markets. If that access tightens, the promise weakens — precisely when the neocloud most needs it to hold.
Now connect it to circularity, because the labs are where the loop closes. A chipmaker or cloud invests in a lab; the lab commits to spend on that investor's compute or silicon; the spending shows up as the investor's demand. The lab is simultaneously the source of end-demand and, sometimes, a recipient of the capital that funds that demand. That is exactly why underwriting the buyer is the crux. If the lab's demand is independent and durable — funded by real end-users paying for real model output — the structures are sound. If the lab's demand is substantially recycled from its own suppliers and investors, the diversification is nominal and the loop is load-bearing. You cannot judge the financing without judging the buyer's independence.
What makes lab demand durable? Three tests.
End-user revenue. Is the lab's compute spending ultimately funded by customers paying for model output, or by capital raises? Spending backed by growing end-user revenue is durable; spending backed only by the next funding round is contingent on capital markets staying open. The higher the ratio of real revenue to compute commitment, the more bankable the anchor contract.
Switching and substitution. Model training is not a permanent claim on a fixed amount of compute. A more efficient architecture, a better training method, or a shift from training toward cheaper inference can cut the compute a lab needs, or move it to different hardware. The demand that looks locked-in by a multi-year contract can be undercut by the lab's own technical progress. Durable demand assumes the workload keeps growing; efficiency gains can bend that curve down.
Commitment quality. Read the contract. A take-or-pay with real penalties and a well-funded counterparty is a strong claim. A soft commitment from a lab that is itself dependent on the next raise is a weak one dressed as a strong one. The security behind the financing is only as good as the enforceability of the promise and the solvency of the party making it.
Tie it back to the stress test. The system-level shock — pushing down AI compute demand — is really a shock to the labs. When you model that shock, you are modeling the labs cutting or failing to grow their compute spend, whether from a funding squeeze, an efficiency breakthrough, or slower end-user adoption. Trace that through the stack: the labs trim spend, neocloud utilization and contracted revenue fall, the debt secured on those contracts is impaired, the chipmakers lose orders, and any investor who funded a lab takes a double hit. The buyer's health is the master variable. Every other cushion in the structure is downstream of it.
The closing discipline, then, is a reordering of attention. The sector sells its story from the silicon up — faster chips, denser clusters, cheaper compute. Underwrite it from the demand down. Start with the labs: how durable, how independent, and how well-funded is their appetite for compute? Then read the financing above them as what it is — a stack of claims on that appetite, each layer lowering the cost of the bet and raising its fragility. Whoever can finance capacity decides who builds it; but whether the capacity is worth financing is decided by the buyers at the top of the stack. Underwrite the buyer, and the rest of the structure finally comes into focus.